Immunopathways in giant cell arteritis and polymyalgia rheumatica

Autoimmunity Reviews

Volumn 3, Issue 1, 2004, Pages 46-53

  Weyand, Cornelia M ^a   Ma Krupa, Wei ^a,b   Goronzy, Jörg J ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Acute phase response; Dendritic cells; Intimal hyperplasia; Macrophages; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ADVENTITIA; APOPTOSIS; ARTERY INTIMA PROLIFERATION; BLOOD VESSEL OCCLUSION; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL INTERACTION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIUM CELL; GIANT CELL ARTERITIS; HUMAN; IMMUNOPATHOGENESIS; INTIMA; MACROPHAGE; NITRATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; REVIEW; RHEUMATIC POLYMYALGIA; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUNICA MEDIA;

EID: 1042267436     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00064-8     Document Type: Review

References (40)

1. Hunder G.G. Clinical features of GCA/PMR. Clin Exp Rheumatol. 18:(4 Suppl 20):2000;S6-S8.
2. Evans J.M., O'Fallon W.M., Hunder G.G. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med. 122:(7):1995;502-507.
3. Cid M.C., Campo E., Ercilla G., et al. Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthrit Rheum. 32:(7):1989;884-893.
4. Weyand C.M., Goronzy J.J. Arterial wall injury in giant cell arteritis. Arthrit Rheum. 42:(5):1999;844-853.
5. Evans J.M., Hunder G.G. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin N Am. 26:(3):2000;493-515.
6. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med. 121:(7):1994;484-491.
7. Hunder G.G. Epidemiology of giant-cell arteritis. Clev Clin J Med. 69:(2):2002;SII79-SII82.
8. Weyand C.M., Hicok K.C., Hunder G.G., Goronzy J.J. The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest. 90:(6):1992;2355-2361.
9. Weyand C.M., Hunder N.N., Hicok K.C., Hunder G.G., Goronzy J.J. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthrit Rheum. 37:(4):1994;514-520.
10. Sneller M.C. Granuloma formation, implications for the pathogenesis of vasculitis. Clev Clin J Med. 69:(Suppl 2):2002;SII40-SII43.
11. Weyand C.M., Goronzy J.J. Pathogenic principles in giant cell arteritis. Int J Cardiol. 75:(Suppl 1):2000;S9-S15.
12. Weyand C.M., Goronzy J.J. Giant cell arteritis as an antigen-driven disease. Rheum Dis Clin N Am. 21:(4):1995;1027-1039.
13. Goronzy J.J., Weyand C.M. Cytokines in giant-cell arteritis. Clev Clin J Med. 69:(Suppl 2):2002;SII91-SII94.
14. Weyand C.M., Wagner A.D., Bjornsson J., Goronzy J.J. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest. 98:(7):1996;1642-1649.
15. Weyand C.M., Goronzy J.J. Pathogenic mechanisms in giant cell arteritis. Clev Clin J Med. 69:(Suppl 2):2002;SII28-SII32.
16. Weyand C.M., Schonberger J., Oppitz U., Hunder N.N., Hicok K.C., Goronzy J.J. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med. 179:(3):1994;951-960.
17. + T cell expansions using selected TCRV and J gene segments at the onset of giant cell arteritis. Arthrit Rheum. 37:(8):1994;1221-1227.
18. Martinez-Taboada V., Hunder N.N., Hunder G.G., Weyand C.M., Goronzy J.J. Recognition of tissue residing antigen by T cells in vasculitic lesions of giant cell arteritis. J Mol Med. 74:(11):1996;695-703.
19. Weyand C.M., Tetzlaff N., Bjornsson J., Brack A., Younge B., Goronzy J.J. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthrit Rheum. 40:(1):1997;19-26.
20. Wagner A.D., Bjornsson J., Bartley G.B., Goronzy J.J., Weyand C.M. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol. 148:(6):1996;1925-1933.
21. Brack A., Geisler A., Martinez-Taboada V.M., Younge B.R., Goronzy J.J., Weyand C.M. Giant cell vasculitis is a T cell-dependent disease. Mol Med. 3:(8):1997;530-543.
22. Krupa W.M., Dewan M., Jeon M.S., et al. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol. 161:(5):2002;1815-1823.
23. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:(6673):1998;245-252.
24. Steinman R.M., Inaba K., Turley S., Pierre P., Mellman I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol. 60:(7):1999;562-567.
25. Steinman R.M., Pack M., Inaba K. Dendritic cell development and maturation. Adv Exp Med Biol. 417:1997;1-6.
26. Weyand C.M. The Dunlop-Dottridge Lecture: the pathogenesis of giant cell arteritis. J Rheumatol. 27:(2):2000;517-522.
27. Rittner H.L., Kaiser M., Brack A., Szweda L.I., Goronzy J.J., Weyand C.M. Tissue-destructive macrophages in giant cell arteritis. Circ Res. 84:(9):1999;1050-1058.
28. Rittner H.L., Hafner V., Klimiuk P.A., Szweda L.I., Goronzy J.J., Weyand C.M. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest. 103:(7):1999;1007-1013.
29. Nikkari S.T., Hoyhtya M., Isola J., Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol. 149:(5):1996;1427-1433.
30. Borkowski A., Younge B.R., Szweda L., et al. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. Am J Pathol. 161:(1):2002;115-123.
31. Kaiser M., Younge B., Bjornsson J., Goronzy J.J., Weyand C.M. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol. 155:(3):1999;765-774.
32. Kaiser M., Weyand C.M., Bjornsson J., Goronzy J.J. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthrit Rheum. 41:(4):1998;623-633.
33. Brack A., Martinez-Taboada V., Stanson A., Goronzy J.J., Weyand C.M. Disease pattern in cranial and large-vessel giant cell arteritis. Arthrit Rheum. 42:(2):1999;311-317.
34. Björnsson J. Histopathology of primary vasculitic disorders. Hoffman G.S., Weyand C.M. Inflammatory diseases of blood vessels. 2002;255-265 Marcel Dekker Inc, New York.
35. + cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest. 94:(3):1994;1134-1140.
36. Murphy K.M., Reiner S.L. The lineage decisions of helper T cells. Nat Rev Immunol. 2:(12):2002;933-944.
37. Lohning M., Richter A., Radbruch A. Cytokine memory of T helper lymphocytes. Adv Immunol. 80:2002;115-181.
38. Grogan J.L., Locksley R.M. T helper cell differentiation: on again, off again. Curr Opin Immunol. 14:(3):2002;366-372.
39. McColl S.R. Chemokines and dendritic cells: a crucial alliance. Immunol Cell Biol. 80:(5):2002;489-496.
40. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 1:(2):2001;135-145.